Abbott, AstraZeneca To Combine Next-Generation Fenofibrate With Crestor In Phase III
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies are aiming to submit the lipid-regulating combination in 2009.
You may also be interested in...
Abbott’s Phase III Fenofibrate Works With Statins
The “how” of lipid-lowering could prove key, analyst tells “The Pink Sheet” DAILY.
Abbott’s Phase III Fenofibrate Works With Statins
The “how” of lipid-lowering could prove key, analyst tells “The Pink Sheet” DAILY.
AstraZeneca Revitalizes Crestor With Atherosclerosis Ad Campaign
Company makes hay from Merck/Schering-Plough's failed Vytorin atherosclerosis trial.